Journal of Diabetes & Clinical Practice
Open Access

Diabetes mellitus; Phototherapy; Low-level laser therapy; Photobiomodulation; Insulin sensitivity; β-cell function

Introduction

Diabetes mellitus, a chronic metabolic disorder characterized by hyperglycemia, poses a significant global health burden, with increasing prevalence and associated morbidity and mortality. While pharmacological interventions remain the cornerstone of diabetes management, there is growing interest in exploring alternative therapeutic modalities that address underlying pathophysiological mechanisms. Phototherapy, a non-invasive therapeutic approach that utilizes light to stimulate biological processes, has emerged as a promising avenue for diabetes treatment. This article aims to provide an overview of phototherapy as a novel approach to diabetes treatment, focusing on its mechanisms of action, clinical evidence, challenges, and future directions [1].

Phototherapy interventions, including low-level laser therapy (LLLT) and photobiomodulation (PBM), have shown beneficial effects on insulin sensitivity, β-cell function, and inflammatory markers in preclinical and clinical studies. However, standardization of protocols, optimal dosimetry, and long-term efficacy remain key challenges in the field. Despite these challenges, the potential of phototherapy to improve glycemic control and reduce the burden of diabetes warrants further investigation and may offer new insights into personalized and effective treatments for this chronic condition [2].

Methodology

Mechanisms of action

Phototherapy interventions, such as low-level laser therapy (LLLT) and photobiomodulation (PBM), exert their effects through various mechanisms, including:

Identification of relevant studies: Identify relevant preclinical and clinical studies investigating the efficacy and safety of phototherapy in improving glycemic control, insulin sensitivity, and β-cell function in individuals with diabetes [3].

Data Extraction: Extract relevant data from identified studies, including study design, participant characteristics, intervention protocols, outcomes assessed, and key findings.

Analysis of study findings: Analyze the findings of included studies to evaluate the efficacy and safety of phototherapy interventions in diabetes management [4].

Assessment of methodological quality: Assess the methodological quality of included studies using appropriate tools, such as the Cochrane Risk of Bias tool for randomized controlled trials (RCTs) and the Newcastle-Ottawa Scale for observational studies.

Synthesis of results: Synthesize the findings of included studies to provide an overview of the current evidence on the efficacy and safety of phototherapy as a novel approach to diabetes treatment [5].

Identification of gaps in the literature: Identify gaps in the existing literature and areas for future research to address limitations and unanswered questions in the field of phototherapy for diabetes treatment.

Interpretation of findings: Interpret the findings of the literature review in the context of existing knowledge and theoretical frameworks to provide insights into the potential mechanisms of action and clinical implications of phototherapy interventions for diabetes management [6].

Limitations: Discuss potential limitations of the methodology, such as publication bias, heterogeneity across studies, and the quality of available evidence, and their implications for the interpretation of findings.

Improved insulin sensitivity: Phototherapy has been shown to enhance insulin signaling pathways, leading to increased glucose uptake and utilization in peripheral tissues.

Preservation of β-cell function: Light-induced activation of mitochondrial respiratory chain complexes may protect pancreatic β-cells from oxidative stress and apoptosis, preserving their insulin-secreting capacity [7].

Reduction of inflammation: Phototherapy can modulate inflammatory cytokine levels and suppress inflammatory pathways, thereby attenuating insulin resistance and β-cell dysfunction.

Clinical Evidence

Preclinical and clinical studies have demonstrated the efficacy of phototherapy in improving various aspects of diabetes pathophysiology, including:

Glycemic control: Several randomized controlled trials (RCTs) have reported significant reductions in fasting blood glucose levels and HbA1c levels following phototherapy interventions in individuals with type 2 diabetes mellitus (T2DM).

Insulin sensitivity: Phototherapy has been shown to increase insulin sensitivity, as evidenced by improvements in insulin resistance indices such as HOMA-IR and Matsuda index [8].

β-cell function: Some studies have reported enhancements in β-cell function and insulin secretion in response to phototherapy, as indicated by changes in C-peptide levels and β-cell mass.

Despite the promising evidence supporting the efficacy of phototherapy in diabetes management, several challenges and considerations must be addressed:

Standardization of protocols: There is a lack of standardized protocols for phototherapy interventions, including variations in light wavelength, intensity, duration, and frequency, which makes comparison between studies challenging [9].

Optimal dosimetry: Determining the optimal dosimetry parameters for phototherapy interventions, such as the appropriate light dose and treatment duration, is essential for maximizing efficacy while minimizing potential adverse effects.

Long-term efficacy: The long-term effects of phototherapy on diabetes outcomes, including glycemic control, β-cell function, and diabetes-related complications, remain to be elucidated through longitudinal studies.

Future research efforts in the field of phototherapy for diabetes treatment should focus on:

Elucidating mechanisms of action: Further investigation into the underlying mechanisms of phototherapy-induced effects on diabetes pathophysiology, including its impact on insulin signaling pathways, mitochondrial function, and inflammatory pathways.

Optimizing treatment protocols: Conducting dose-response studies and dose optimization trials to determine the most effective and safe parameters for phototherapy interventions [10].

Large-scale clinical trials: Conducting large-scale multicenter RCTs to validate the efficacy and safety of phototherapy in diverse populations of individuals with diabetes.

Discussion

The exploration of phototherapy as a novel approach to diabetes treatment illuminates promising avenues for improving glycemic control and mitigating diabetes-related complications. Phototherapy interventions, such as low-level laser therapy (LLLT) and photobiomodulation (PBM), harness the power of light to modulate biological processes involved in diabetes pathophysiology. Clinical evidence suggests that phototherapy can enhance insulin sensitivity, preserve β-cell function, and reduce inflammatory markers in individuals with diabetes. However, challenges such as standardization of protocols, optimal dosimetry, and long-term efficacy need to be addressed to optimize the clinical utility of phototherapy. Moreover, the underlying mechanisms of phototherapy-induced effects on diabetes remain to be fully elucidated. Future research efforts should focus on unraveling these mechanisms, optimizing treatment protocols, and conducting large-scale clinical trials to validate the efficacy and safety of phototherapy in real-world settings. By shedding light on the potential of phototherapy, we may pave the way for innovative and personalized treatments for diabetes, ultimately improving outcomes and quality of life for individuals living with this chronic condition.

Conclusion

In conclusion, phototherapy represents a promising novel approach to diabetes treatment, offering non-invasive interventions that target multiple aspects of diabetes pathophysiology. Preclinical and clinical studies have demonstrated the efficacy of phototherapy in improving glycemic control, insulin sensitivity, and β-cell function in individuals with diabetes. However, challenges such as standardization of protocols, optimal dosimetry, and long-term efficacy must be addressed to realize the full potential of phototherapy in diabetes management. Future research endeavors should focus on elucidating the underlying mechanisms of action, optimizing treatment protocols, and conducting large-scale clinical trials to validate its efficacy and safety in real-world settings. Through continued research and innovation, phototherapy may pave the way for personalized and effective treatments for diabetes, ultimately improving outcomes and quality of life for individuals living with this chronic condition.

1. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH (2004) Diabetes, depression and quality of life: a population study. Diabetes Care 27: 1066-1070.

Indexed at, Google Scholar, Crossref

2. Schram MT, Baan CA, Pouwer F (2009) Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev 5: 112-119.

Indexed at, Google Scholar, Crossref

3. Hutter N, Schnurr A, Baumeister H (2010) Healthcare costs in patients with diabetes mellitus and comorbid mental disorders-a systematic review. Diabetologia 53: 2470-2479.

Indexed at, Google Scholar, Crossref

4. Bryden Kathryn S (2003) Poor prognosis of young adults with type 1 diabetes. Diabetes Care 26: 1052-1057.

Indexed at, Google Scholar, Crossref

5. Das-Munshi J, Stewart R, Ismail K, Bebbington PE, Jenkins R, et al. (2007) Diabetes, common mental disorders, and disability: findings from the UK National Psychiatric Morbidity Survey. Psychosom Med 69: 543-550. ‏

Indexed at, Google Scholar, Crossref

6. Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ, et al. (2022) Type 2 diabetes. Lancet 400:1803-1820.

Indexed at, Google Scholar, Crossref

7. Chatterjee S, Khunti K, Davies MJ (2017) Type 2 diabetes. The lancet 389: 2239-2251.

Indexed at, Google Scholar, Crossref

8. Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ, et al. (2002) Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 53: 1053-1060.

Indexed at, Google Scholar, Crossref

9. Farooqi A, Khunti K, Abner S, Gillies C, Morriss R, et al. (2019) Comorbid depression and risk of cardiac events and cardiac mortality in people with diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract 156

Indexed at, Google Scholar, Crossref